Effect of subcutaneous semaglutide 2.4 mg once-weekly compared to placebo in subjects with obesity and knee osteoarthritis
عنوان الدراسة
Effect of subcutaneous semaglutide 2.4 mg once-weekly compared to placebo in subjects with obesity and knee osteoarthritis
داعم الدراسة
Novo Nordisk
دواء الدراسة
semaglutide
رقم بروتوكول الدراسة
NN9536-4578
حالة الدراسة
Ongoing
موقع الدراسة
King Fahad Medical City (Riyadh)
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.